EXFORGEHCT
Live / Registered — Registered and renewed (as of 23 Mar 2022)
What this means for you
Registered since 24 Jan 2012. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 24 Jan 2022).
Record
- Serial number
- 85139553
- Registration number
- 4091926
- Mark type
- Word mark
- Filed
- 28 Sept 2010
- Published for opposition
- 22 Feb 2011
- Registered
- 24 Jan 2012
- Next maintenance due
- 24 Jan 2022
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of metabolic diseases and disorders
Owner
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
- Novartis AG, Basel, CH
Prior registrations
Prosecution history
- 23 Mar 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Mar 2022 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 23 Mar 2022 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 21 Mar 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 11 Nov 2021 — TEAS SECTION 8 & 9 RECEIVED
- 24 Jan 2021 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 06 Jan 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 06 Jan 2018 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 06 Jan 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 10 Dec 2017 — TEAS SECTION 8 & 15 RECEIVED
- 24 Jan 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Jan 2012 — REGISTERED-PRINCIPAL REGISTER
- 21 Dec 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Dec 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 13 Dec 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED